Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant LifeSciences has informed that the Board of Directors of the Company shall, at its meeting scheduled to be held on Wednesday, June 27, 2018, to consider the proposal to issue Non-Convertible Debentures up to an amount of Rs 750 Crore.
The above information is a part of company’s filings submitted to BSE.